Published in Cancer on August 01, 1984
Immunohistochemistry in bone marrow pathology: a useful adjunct for morphologic diagnosis. Virchows Arch (2005) 0.91
Hairy cell leukemia treatment: where we are now? Mater Sociomed (2011) 0.75
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med (1987) 13.84
Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science (1984) 10.40
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med (1987) 8.52
HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science (1985) 7.70
Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med (1985) 6.54
Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein. Science (1986) 5.25
Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen. Science (1987) 4.31
Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene. Proc Natl Acad Sci U S A (1985) 4.28
Designing CD4 immunoadhesins for AIDS therapy. Nature (1989) 4.00
The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell (1994) 3.91
Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science (1978) 3.91
Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils. Science (1984) 3.84
Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. Science (1985) 3.81
Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome. Lancet (1984) 3.77
Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator. Nature (1985) 3.73
Human T lymphotropic virus type III infection of human alveolar macrophages. Blood (1986) 3.66
Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist (2000) 3.62
HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS. Science (1984) 3.50
The acquired immunodeficiency syndrome. Ann Intern Med (1983) 3.49
HTLV-III in cells cultured from semen of two patients with AIDS. Science (1984) 3.47
Identification of the putative transforming protein of the human T-cell leukemia viruses HTLV-I and HTLV-II. Science (1984) 3.39
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol (1997) 3.27
Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science (1988) 3.22
A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses. Science (1986) 3.20
A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. Science (1985) 3.05
A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med (1989) 2.95
Myelodysplasia. N Engl J Med (1999) 2.94
The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem (1998) 2.88
Amygdalin (Laetrile): effect on clonogenic cells from human myeloid leukemia cell lines and normal human marrow. Cancer Treat Rep (1980) 2.86
The pulmonary-alveolar macrophage (first of two parts). N Engl J Med (1979) 2.85
HTLV-III in symptom-free seronegative persons. Lancet (1984) 2.71
Nucleotide sequence analysis of the long terminal repeat of human T-cell leukemia virus type II. Proc Natl Acad Sci U S A (1984) 2.67
Localization of gelsolin proximal to ABL on chromosome 9. Am J Hum Genet (1988) 2.64
Human T-cell leukemia virus type II transforms normal human lymphocytes. Proc Natl Acad Sci U S A (1983) 2.41
Long terminal repeats of human T-cell leukaemia virus II genome determine target cell specificity. Nature (1984) 2.39
Molecular characterization of genome of a novel human T-cell leukaemia virus. Nature (1983) 2.36
Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1988) 2.34
Association of human T lymphotropic virus type III antibodies with sexual and other behaviors in a cohort of homosexual men from Boston with and without generalized lymphadenopathy. Am J Med (1986) 2.33
Identification of the colony-stimulating cell in human peripheral blood. J Clin Invest (1972) 2.33
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Engl J Med (1987) 2.31
Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. J Immunol (1986) 2.31
Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature (1985) 2.25
Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science (1976) 2.23
Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. N Engl J Med (1985) 2.20
Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain. J Biol Chem (1995) 2.17
Nucleotide sequence of the 3' region of an infectious human T-cell leukemia virus type II genome. Proc Natl Acad Sci U S A (1984) 2.10
Biological properties of a CD4 immunoadhesin. Nature (1990) 2.05
Chronic myelogenous leukemia: recent advances. Blood (1985) 1.99
Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid. Nature (1993) 1.97
Human myeloid leukemia cell lines: a review. Blood (1980) 1.96
Evidence for two distinct c-src loci on human chromosomes 1 and 20. Nature (1984) 1.91
Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders. Science (1986) 1.91
Suppression of in vitro haematopoiesis following human immunodeficiency virus infection. Nature (1987) 1.91
Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization. Science (1990) 1.90
Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med (1990) 1.89
Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston. Ann Intern Med (1985) 1.89
Human T-lymphotropic virus type III in high-risk, antibody-negative homosexual men. Ann Intern Med (1986) 1.88
An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood (1980) 1.86
Localization of the gene encoding human erythroid-potentiating activity to chromosome region Xp11.1----Xp11.4. Am J Hum Genet (1986) 1.84
Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group. JAMA (1989) 1.84
Haematologic manifestations of the human immune deficiency virus (HIV). Br J Haematol (1987) 1.83
The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study. Ann Intern Med (1990) 1.82
Macrophage-active colony-stimulating factors enhance human immunodeficiency virus type 1 infection in bone marrow stem cells. Blood (1991) 1.80
CD4+ lymphocyte function with early human immunodeficiency virus infection. Proc Natl Acad Sci U S A (1989) 1.78
Myotilin is mutated in limb girdle muscular dystrophy 1A. Hum Mol Genet (2000) 1.78
Production of colony-stimulating activity by human lymphocytes. Nature (1974) 1.78
High-affinity binding of granulocyte-macrophage colony-stimulating factor to normal and leukemic human myeloid cells. Proc Natl Acad Sci U S A (1986) 1.76
Regulation of expression of human granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci U S A (1986) 1.76
Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils. Blood (1986) 1.74
The first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocations in chronic myelogenous leukemia. Mol Cell Biol (1987) 1.73
Human monocarboxylate transporter 2 (MCT2) is a high affinity pyruvate transporter. J Biol Chem (1998) 1.71
Production of erythroid-potentiating activity by a human T-lymphoblast cell line. Proc Natl Acad Sci U S A (1980) 1.71
A review and reevaluation of the histiocytic disorders. Am J Med (1973) 1.66
Studies of the putative transforming protein of the type I human T-cell leukemia virus. Science (1985) 1.65
Characterization of serum neutralization response to the human immunodeficiency virus (HIV). AIDS Res Hum Retroviruses (1987) 1.65
Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants. Blood (1987) 1.63
Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence. J Natl Cancer Inst (1999) 1.63
Production of tumor necrosis factor alpha and interleukin 1 beta by monocytic cells infected with human immunodeficiency virus. J Clin Invest (1989) 1.61
The human gene encoding GM-CSF is at 5q21-q32, the chromosome region deleted in the 5q- anomaly. Science (1985) 1.61
Abdominal presentation of varicella-zoster infection in recipients of allogeneic bone marrow transplantation. Bone Marrow Transplant (1991) 1.59
T-lymphocyte variant of hairy-cell leukemia. Ann Intern Med (1978) 1.56
Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc Natl Acad Sci U S A (1993) 1.56
Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia. Proc Natl Acad Sci U S A (1988) 1.56
Bone marrow origin of hepatic macrophages (Kupffer cells) in humans. Science (1978) 1.53
Biosynthetic (recombinant) human granulocyte-macrophage colony-stimulating factor: effect on normal bone marrow and leukemia cell lines. Blood (1986) 1.51
The histiocytic disorders: a pathophysiologic analysis. Ann Intern Med (1981) 1.50
Serum cholesterol-lowering activity of granulocyte-macrophage colony-stimulating factor. JAMA (1988) 1.49
Serological characterization of HTLV-III infection in AIDS and related disorders. J Infect Dis (1986) 1.47
The 5q- abnormality. Blood (1987) 1.47
Immunologic characterization of hairy cell leukemias in continuous culture. J Immunol (1978) 1.47
Hairy cell leukemia: a clinical review based on 71 cases. Ann Intern Med (1978) 1.46
Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors. J Immunol (1986) 1.46
Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells. J Biol Chem (2000) 1.46
Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells. J Biol Chem (1993) 1.45
Defective lung macrophages in pulmonary alveolar proteinosis. Ann Intern Med (1976) 1.45
HTLV x-gene product: requirement for the env methionine initiation codon. Science (1985) 1.45